Renaissance Technologies’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3M | Buy |
368,100
+164,100
| +80% | +$1.34M | ﹤0.01% | 1845 |
|
2025
Q1 | $1.6M | Buy |
204,000
+185,500
| +1,003% | +$1.46M | ﹤0.01% | 2138 |
|
2024
Q4 | $275K | Sell |
18,500
-165,400
| -90% | -$2.46M | ﹤0.01% | 3072 |
|
2024
Q3 | $2.81M | Buy |
183,900
+101,500
| +123% | +$1.55M | ﹤0.01% | 1800 |
|
2024
Q2 | $1.25M | Sell |
82,400
-158,100
| -66% | -$2.41M | ﹤0.01% | 2195 |
|
2024
Q1 | $4.54M | Buy |
240,500
+117,000
| +95% | +$2.21M | 0.01% | 1477 |
|
2023
Q4 | $2.36M | Sell |
123,500
-19,300
| -14% | -$369K | ﹤0.01% | 1855 |
|
2023
Q3 | $2.56M | Buy |
+142,800
| New | +$2.56M | ﹤0.01% | 1709 |
|
2021
Q3 | – | Sell |
-275,700
| Closed | -$7.57M | – | 3776 |
|
2021
Q2 | $7.57M | Buy |
275,700
+18,800
| +7% | +$516K | 0.01% | 1372 |
|
2021
Q1 | $7.21M | Buy |
+256,900
| New | +$7.21M | 0.01% | 1415 |
|
2020
Q2 | – | Sell |
-261,416
| Closed | -$3.63M | – | 3708 |
|
2020
Q1 | $3.63M | Buy |
261,416
+44,178
| +20% | +$613K | ﹤0.01% | 1751 |
|
2019
Q4 | $2.19M | Buy |
217,238
+76,400
| +54% | +$772K | ﹤0.01% | 2285 |
|
2019
Q3 | $1.28M | Buy |
140,838
+106,238
| +307% | +$967K | ﹤0.01% | 2493 |
|
2019
Q2 | $275K | Buy |
+34,600
| New | +$275K | ﹤0.01% | 3202 |
|